METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATING TYPE 1 DIABETES MELLITUS AND OTHER CONDITIONS

摘要

Type 1 diabetes mellitus and other conditions relating to inadequate insulin or diminished levels of insulin can be treated by administering a pancreatic islet cell regeneration agent and/or an agent that transforms pancreatic ductal cells to islet cells in combination with administration of an agent that selectively inhibits, blocks, or destroys the autoimmune cells that target pancreatic islet cells.